Source: BioPharma-Reporter

Sekisui: SEKISUI Diagnostics completes 15.7M expansion to boost biopharma manufacturing capacity

New cGMP fermentation facility in the UK set to meet growing demand for drug substance production, supporting biopharma manufacturing at scale.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Robert Schruender's photo - President & CEO of Sekisui

President & CEO

Robert Schruender

CEO Approval Rating

87/100

Read more